Julia K. Rotow, Md

This study tests whether a simple blood test can tell if a lung cancer drug (pembrolizumab) is working early on. About 40 people with stage IV non-small cell lung cancer will have blood drawn at different times. If the test shows the drug isn't working well, patients may switch t…